Robert Redfield, MD
Transplant Surgery · Orange, CANPI 1326195082
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,397 of the $65,439 with a category attached, or 74.0%. 12 manufacturers reported payments, led by Veloxis Pharmaceuticals, Inc. at 50.6% of the total. Reporting peaked in 2021 at $28,777 and has fallen 93.7% since, to $1,811 in 2025. Among transplant surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $711.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$33K
- Genentech, Inc.$13K
- Regeneron$11K
- Intuitive Surgical$4K
- Medical Device Business Services, Inc.$3K
- Johnson & Johnson$1K
- plus $1K from 6 others
Across 151 payments — averaging $6875.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$515K
- Regeneron$486K
- Roche Products Limited$38K
What the payments were for
- Consulting fees$48,39774%
- Speaking & faculty fees$1,1502%
- Travel & lodging$9,08214%
- Food & beverage$3,8106%
- Education$3,0005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 33 | $33,110 |
| Genentech, Inc. | 4 | $12,578 |
| Regeneron | 16 | $10,964 |
| Intuitive Surgical | 7 | $3,778 |
| Medical Device Business Services, Inc. | 3 | $2,609 |
| Johnson & Johnson | 19 | $1,008 |
| Sanofi-aventis U.S. LLC | 3 | $391 |
| ZOLL Medical Corporation | 1 | $367 |
| Dilon Technologies, Inc. | 2 | $247 |
| Paragonix Technologies, Inc. | 2 | $175 |
| Eurofins Viracor, LLC | 1 | $150 |
| Pfizer | 1 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$32,772
- Da Vinci Surgical System$3,620
- Echelon Flex$2,750
- VISTASEAL$2,750
- Harmonic$2,643
- THYMOGLOBULIN$391
- Defibrillator$367
- ETHICON$340
- PDS$232
- HemoBlast Bellows$150
- SherpaPak$141
- LIVERguard$141
- LUNGguard$141
- BaroGuard$141
- PancreasPak$141
- STRATAFIX$127
- SURGICEL NU-KNIT$118
- DERMABOND$106
How this compares
$65,439 in reported general payments places this provider in the 95th percentile of 56 transplant surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Orange
- Christina PapageorgeOrange$4K
- Ervin RuzicsOrange$316
- Caroline TranOrange$145
- Hirohito IchiiOrange$125
- Elizabeth SquiersHalf Moon Bay$1.3M
- Myron TongPasadena$99K
- Yuri GenykLos Angeles$35K
- Angeles Baquerizola Jolla$28K
- Navpreet KaurLos Angeles$19K
- Gerald LipshutzLos Angeles$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.